177 related articles for article (PubMed ID: 37599194)
1. Prognostic impact of postoperative infection after resection of biliary malignancy: A multicenter retrospective cohort study.
Iseki M; Mizuma M; Unno M; Maruyama H; Akagi S; Shimoda M; Uemura K; Inoue T; Shiomi H; Watanabe M; Kobayashi M; Matsuda A; Mizuuchi Y; Aoki T; Shinkawa H; Takahata R; Makino K; Arai H; Yokoyama Y; Takeda S; Yaguchi Y; Kitagawa Y
Surgery; 2023 Nov; 174(5):1145-1152. PubMed ID: 37599194
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection.
Utsumi M; Kitada K; Tokunaga N; Yoshida Y; Narusaka T; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S; Inagaki M
Anticancer Res; 2021 Apr; 41(4):2147-2155. PubMed ID: 33813426
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
[TBL] [Abstract][Full Text] [Related]
4. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
[TBL] [Abstract][Full Text] [Related]
6. Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas.
Sallinen V; Sirén J; Mäkisalo H; Lehtimäki TE; Lantto E; Kokkola A; Nordin A
Scand J Surg; 2020 Sep; 109(3):219-227. PubMed ID: 30791825
[TBL] [Abstract][Full Text] [Related]
7. Gallbladder cancer mimicking perihilar cholangiocarcinoma-considerable rate of postoperative reclassification with implications for prognosis.
Nooijen LE; Gustafsson-Liljefors M; Erdmann JI; D'Souza MA; Gilg S; Villard C; Jansson H
World J Surg Oncol; 2023 Sep; 21(1):286. PubMed ID: 37697321
[TBL] [Abstract][Full Text] [Related]
8. Age trends in biliary tract cancer incidence by anatomical subtype: A Swedish cohort study.
Rahman R; Ludvigsson JF; von Seth E; Lagergren J; Bergquist A; Radkiewicz C
Eur J Cancer; 2022 Nov; 175():291-298. PubMed ID: 36174301
[TBL] [Abstract][Full Text] [Related]
9. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
Ma KW; Cheung TT; She WH; Chok KSH; Chan ACY; Dai WC; Chiu WH; Lo CM
World J Surg; 2018 Mar; 42(3):823-834. PubMed ID: 28905105
[TBL] [Abstract][Full Text] [Related]
11. Influencing factors of biliary fistula after radical resection of hilar cholangiocarcinoma: a prospect cohort.
Zhang D; Qi F; Sun W; Zhao G; Wang D; Zhou S; Liu Z; Lu Z
Eur J Med Res; 2022 Oct; 27(1):214. PubMed ID: 36307886
[TBL] [Abstract][Full Text] [Related]
12. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
[TBL] [Abstract][Full Text] [Related]
13. S4a + S5 with caudate lobe (S1) resection using the Taj Mahal liver parenchymal resection for carcinoma of the biliary tract.
Kawarada Y; Isaji S; Taoka H; Tabata M; Das BC; Yokoi H
J Gastrointest Surg; 1999; 3(4):369-73. PubMed ID: 10482688
[TBL] [Abstract][Full Text] [Related]
14. Mild Prognostic Impact of Postoperative Complications on Long-term Survival of Perihilar Cholangiocarcinoma.
Kawakatsu S; Ebata T; Watanabe N; Onoe S; Yamaguchi J; Mizuno T; Igami T; Yokoyama Y; Matsuo K; Nagino M
Ann Surg; 2022 Jul; 276(1):146-152. PubMed ID: 32889874
[TBL] [Abstract][Full Text] [Related]
15. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma.
Hochwald SN; Burke EC; Jarnagin WR; Fong Y; Blumgart LH
Arch Surg; 1999 Mar; 134(3):261-6. PubMed ID: 10088565
[TBL] [Abstract][Full Text] [Related]
16. Pre-operative Sarcopenia Identifies Patients at Risk for Poor Survival After Resection of Biliary Tract Cancers.
Chakedis J; Spolverato G; Beal EW; Woelfel I; Bagante F; Merath K; Sun SH; Chafitz A; Galo J; Dillhoff M; Cloyd J; Pawlik TM
J Gastrointest Surg; 2018 Oct; 22(10):1697-1708. PubMed ID: 29855867
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impacts of postoperative complications in patients with intrahepatic cholangiocarcinoma after curative operations.
Miyata T; Yamashita YI; Yamao T; Umezaki N; Tsukamoto M; Kitano Y; Yamamura K; Arima K; Kaida T; Nakagawa S; Imai K; Hashimoto D; Chikamoto A; Ishiko T; Baba H
Int J Clin Oncol; 2017 Jun; 22(3):526-532. PubMed ID: 28205002
[TBL] [Abstract][Full Text] [Related]
18. One hundred consecutive hepatobiliary resections for biliary hilar malignancy: preoperative blood donation, blood loss, transfusion, and outcome.
Nagino M; Kamiya J; Arai T; Nishio H; Ebata T; Nimura Y
Surgery; 2005 Feb; 137(2):148-55. PubMed ID: 15674194
[TBL] [Abstract][Full Text] [Related]
19. Preoperative biliary MRSA infection in patients undergoing hepatobiliary resection with cholangiojejunostomy: incidence, antibiotic treatment, and surgical outcome.
Takara D; Sugawara G; Ebata T; Yokoyama Y; Igami T; Nagino M
World J Surg; 2011 Apr; 35(4):850-7. PubMed ID: 21327600
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
